Maha deradicalisation programme only for minorities; saffron terrorism ignored

[email protected] (CD Network)
February 4, 2016

Mumbai, Feb 4: In a narrow-minded move, the Maharashtra government has rolled out a deradicalisation programme targeting only minority community. The programme has completely ignored the saffron terrorism.

terrorThe proposal includes opening vyayam shalas in minority areas, making National Cadet Corps (NCC), Bharat Scouts and Guides (BS&G) compulsory in minority schools, and setting up an independent media outlet to deliver ‘mainstream thoughts and values’ to the minority youth in the State.

The Union Home Ministry had asked three States to draw up a comprehensive counter-strategy in the wake of attempts by international terrorist outfits to propagate what they call ‘jihadi’ ideologies.

A three-member team of the Maharashtra’s Anti-Terrorism Squad (ATS) led by Director General of Police (DGP) Pravin Dixit had presented an IS counter-strategy at New Delhi in the second week of January.

Concurrently, the State Home Department has rolled out a 50-point socio-economic strategy with the aim of ‘bringing youth of the minority community into the mainstream’ and making coordinated efforts and policies in 13 sectors, including education, sports, urban planning, law and order, skill development, women and child, social justice, and health.

Chief Minister Devendra Fadnavis has approved the proposal and passed a government resolution on it. The proposed responses drawn up against the threat of home-grown extremism include: plans to teach religious texts from all sects in minority schools and teaching merits of democratic States and demerits of dictatorships as a separate chapter in the Urdu textbooks.

Comments

Muhammad
 - 
Thursday, 4 Feb 2016

Are they teaching Fadnavis's RSS theology ...???In the disguise of deradacalising.. Is Hindu swabhiman sangatan and Sanathan Sanstha pet of Fadnavis BJP and RSS so that they are immune of govt policy...,,???

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 19,2020

Belagavi,  Jul 19: In a heart-wrenching incident, a woman used a pushcart to take the body of her dead husband to the crematorium after she allegedly did not receive any help from relatives who suspected him to have died of Covid.

The woman and her son were seen pushing the body in the Athani thaluk of Belagavi.

The man had died two days ago at his residence and no family member apart from the close members attended the last rites due to the fear that he was COVID-19 positive.

It was later found that the deceased person was COVID-19 negative.

A total of 3,693 new COVID-19 positive cases and 115 deaths were reported in Karnataka on Friday, said the state health department.

The total number of COVID-19 cases in the state is presently at 55,115, including 33,205 active cases. While there are 20,757 recoveries, the death toll stands at 1,147.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 12,2020

Bengaluru, Mar 12: Karnataka government on Wednesday issued a temporary regulation -- Karnataka Epidemic Diseases, COVID-19 Regulations, 2020 -- which aims to prevent the spread of the disease.

According to the regulation, all government and private hospitals should have flu corners for the screening of suspected cases of COVID-19.

All hospitals during the screening of such cases shall record the history of travel of the person if he or she has travelled to any country or area where COVID-19 has been reported in addition to the history of coming in contact with a suspected or confirmed case of COVID-19 shall be recorded.

Any person with a history of travel in the last 14 days to a country or area from where COVID-19 has been reported must report to the nearest government hospital or call at toll-free helpline number 104 so that necessary measures if required, may be initiated by the Department of Health and Family Welfare.

If a suspected case of COVID-19 refuses admission or isolation, the offices authorised under Section 3 of the regulation shall have powers to forcefully admit and isolate such case of a period of 14 days from the onset of symptoms or till the reports of lab tests are received, or such period as may be necessary.

No person, institution or organisation shall use print or electronic media to spread misinformation on COVID19. If a person is found indulging in any such activity, they will be punished.

If the cases of COVID-19 are reported from a defined geographic area, the district administration of the concerned district shall have the right to implement the following containment measures but not limited to these in order to prevent the spread of diseases:

* Sealing of geographic

* Barring of entry and exit of the population from the containment area

* Closure of schools, offices and banning public gathering

* Banning vehicular movement in the area

* Designating any government or private building as a containment unit for the isolation of cases

* The staff of all govt departments shall be at the disposal of the concerned district administration of the concerned area for discharging the duty of containment measures

Any person, institution or organisation found violating any of these regulations, shall be deemed to have committed an offence punishable under section 188 of the Indian Penal Code (IPC).

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.